Bartizal Ken 4
4 · Trius Therapeutics Inc · Filed May 28, 2013
Insider Transaction Report
Form 4
Bartizal Ken
Chief Development Officer
Transactions
- Sale
Common Stock
2013-05-24$7.93/sh−12,000$95,119→ 98,927 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012